指南与共识外周血管神经技术与安全USMRPET

大血管血管炎的诊断、监测和结局预测中的影像学:为2023年EULAR推荐更新提供信息的系统文献综述和荟萃分析

Imaging in diagnosis, monitoring and outcome prediction of large vessel vasculitis: a systematic literature review and meta-analysis informing the 2023 update of the EULAR recommendations.
指南 / 共识 · RMD Open · 2023-01-01

该系统文献综述和荟萃分析更新了影像学诊断、监测和预测大血管血管炎结局的证据,共纳入81项研究。低偏倚风险研究中,超声、MRI和FDG-PET对巨细胞动脉炎的汇总敏感度分别为88%、81%和76%,特异度分别为96%、98%和95%;超声评估颅内外动脉较仅评估颅动脉敏感度更高(93% vs 80%),特异度相似。未发现影像学严重程度可预测更差临床结局的证据。

要点

  • 超声、MRI和FDG-PET对巨细胞动脉炎诊断具有良好的汇总敏感度和特异度。
  • 超声同时评估颅内外动脉较仅评估颅动脉敏感度更高(93% vs 80%),特异度相似。
  • 未发现影像学严重程度可预测更差临床结局的证据,监测研究仅报告影像与临床炎症征象的关联。

核心结论

  • 超声、MRI和FDG-PET对巨细胞动脉炎诊断表现出良好性能;超声同时评估颅内外动脉较仅评估颅动脉具有更高的汇总敏感度,特异度相似;未发现影像学严重程度可预测更差临床结局的证据。

研究设计与样本

  • 系统文献综述和荟萃分析,检索2017-2022年文献,纳入前瞻性队列和横断面研究(参与者>20),诊断准确性数据与2017年系统文献综述数据合并进行荟萃分析。

诊断标准与关键数值

  • 以临床诊断为参考标准,低偏倚风险研究中超声诊断巨细胞动脉炎的汇总敏感度88%(95%CI 82%至92%),特异度96%(95%CI 86%至99%)(n=8项研究)。
  • 以临床诊断为参考标准,低偏倚风险研究中MRI诊断巨细胞动脉炎的汇总敏感度81%(95%CI 71%至89%),特异度98%(95%CI 89%至100%)(n=3项研究)。
  • 以临床诊断为参考标准,低偏倚风险研究中FDG-PET诊断巨细胞动脉炎的汇总敏感度76%(95%CI 67%至83%),特异度95%(95%CI 71%至99%)(n=4项研究)。
  • 低偏倚风险研究中,超声同时评估颅内外动脉较仅评估颅动脉的汇总敏感度更高(93%(95%CI 88%至96%) vs 80%(95%CI 71%至87%)),特异度相似(94%(95%CI 83%至98%) vs 97%(95%CI 71%至100%))。

临床应用与阅片要点

  • 以临床诊断为参考标准,超声、MRI和FDG-PET对巨细胞动脉炎诊断具有良好性能。
  • 超声同时评估颅内外动脉较仅评估颅动脉可提高汇总敏感度,特异度相似。

局限性

  • 未发现新的关于大血管炎诊断影像学的研究。
  • 未发现影像学严重程度可预测更差临床结局的证据。
  • 一些监测研究仅报告影像与临床炎症征象的关联。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To update the evidence on imaging for diagnosis, monitoring and outcome prediction in large vessel vasculitis (LVV) to inform the 2023 update of the European Alliance of Associations for Rheumatology recommendations on imaging in LVV.

METHODS: Systematic literature review (SLR) (2017-2022) including prospective cohort and cross-sectional studies (>20 participants) on diagnostic, monitoring, outcome prediction and technical aspects of LVV imaging. Diagnostic accuracy data were meta-analysed in combination with data from an earlier (2017) SLR.

RESULTS: The update retrieved 38 studies, giving a total of 81 studies when combined with the 2017 SLR. For giant cell arteritis (GCA), and taking clinical diagnosis as a reference standard, low risk of bias (RoB) studies yielded pooled sensitivities and specificities (95% CI) of 88% (82% to 92%) and 96% (95% CI 86% to 99%) for ultrasound (n=8 studies), 81% (95% CI 71% to 89%) and 98% (95% CI 89% to 100%) for MRI (n=3) and 76% (95% CI 67% to 83%) and 95% (95% CI 71% to 99%) for fluorodeoxyglucose positron emission tomography (FDG-PET, n=4), respectively. Compared with studies assessing cranial arteries only, low RoB studies with ultrasound assessing both cranial and extracranial arteries revealed a higher sensitivity (93% (95% CI 88% to 96%) vs 80% (95% CI 71% to 87%)) with comparable specificity (94% (95% CI 83% to 98%) vs 97% (95% CI 71% to 100%)). No new studies on diagnostic imaging for Takayasu arteritis (TAK) were found. Some monitoring studies in GCA or TAK reported associations of imaging with clinical signs of inflammation. No evidence was found to determine whether imaging severity might predict worse clinical outcomes.

CONCLUSION: Ultrasound, MRI and FDG-PET revealed a good performance for the diagnosis of GCA. Cranial and extracranial vascular ultrasound had a higher pooled sensitivity with similar specificity compared with limited cranial ultrasound.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Bosch P, Bond M, Dejaco C, et al. Imaging in diagnosis, monitoring and outcome prediction of large vessel vasculitis: a systematic literature review and meta-analysis informing the 2023 update of the EULAR recommendations. RMD Open. 2023. PMID: 37620113. doi:10.1136/rmdopen-2023-003379

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。